Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations

We reviewed the current information available on nevirapine immediate- and extended-release formulations and its role in single-dose and combination antiretroviral therapy. Nevirapine was approved in 1996 and was the first non-nucleoside reverse-transcriptase inhibitor available for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ena, Javier, Amador, Concepción, Benito, Conxa, Pasquau, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501953/
https://www.ncbi.nlm.nih.gov/pubmed/23172991
http://dx.doi.org/10.2147/HIV.S35564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501953/
https://www.ncbi.nlm.nih.gov/pubmed/23172991
http://dx.doi.org/10.2147/HIV.S35564

Ejemplares similares